{"certainAgreement":{"otherDetails":"Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than one year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to ninety days; Investigator must delete confidential information before submission or defer publication to permit patent applications","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"ClinicalTrialDisclosure@celgene.com","organization":"Celgene Corporation","phone":"888-260-1599","title":"Anne McClain, Senior Manager, Clinical Trial Disclosure"}}